Anna Kathy Aman

Array ( [id] => 7674123 [patent_doc_number] => 20040127995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Conformable, absorbable, solid composite preforms and their use for bone tissue engineering' [patent_app_type] => new [patent_app_number] => 10/626894 [patent_app_country] => US [patent_app_date] => 2003-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5358 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127995.pdf [firstpage_image] =>[orig_patent_app_number] => 10626894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686873 [patent_doc_number] => 07078398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-18 [patent_title] => 'Compositions and methods for treating or preventing convulsions or seizures' [patent_app_type] => utility [patent_app_number] => 10/625754 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6464 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078398.pdf [firstpage_image] =>[orig_patent_app_number] => 10625754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 472758 [patent_doc_number] => 07229982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-12 [patent_title] => 'Pharmaceutical formulation' [patent_app_type] => utility [patent_app_number] => 10/625004 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5231 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/229/07229982.pdf [firstpage_image] =>[orig_patent_app_number] => 10625004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1105382 [patent_doc_number] => 06812253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-02 [patent_title] => '4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical' [patent_app_type] => B2 [patent_app_number] => 10/623775 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4379 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812253.pdf [firstpage_image] =>[orig_patent_app_number] => 10623775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7169355 [patent_doc_number] => 20040077629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/625866 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5070 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077629.pdf [firstpage_image] =>[orig_patent_app_number] => 10625866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401329 [patent_doc_number] => 20040019032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Treatment of macular edema' [patent_app_type] => new [patent_app_number] => 10/622310 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13867 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019032.pdf [firstpage_image] =>[orig_patent_app_number] => 10622310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395884 [patent_doc_number] => 20040018257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Use of unsaponifiable components of vegetable oils for preparing a cosmetic and related treatments' [patent_app_type] => new [patent_app_number] => 10/619686 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7941 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018257.pdf [firstpage_image] =>[orig_patent_app_number] => 10619686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089693 [patent_doc_number] => 20050009806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING AN ACE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 10/618548 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2779 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009806.pdf [firstpage_image] =>[orig_patent_app_number] => 10618548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467961 [patent_doc_number] => 20040053889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Pharmaceutical use of boronic acids and esters thereof' [patent_app_type] => new [patent_app_number] => 10/614233 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13791 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053889.pdf [firstpage_image] =>[orig_patent_app_number] => 10614233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468750 [patent_doc_number] => 20040053989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement' [patent_app_type] => new [patent_app_number] => 10/612476 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32722 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053989.pdf [firstpage_image] =>[orig_patent_app_number] => 10612476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946650 [patent_doc_number] => 06964984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-15 [patent_title] => 'Preventing desensitization of receptors' [patent_app_type] => utility [patent_app_number] => 10/608120 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3313 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/964/06964984.pdf [firstpage_image] =>[orig_patent_app_number] => 10608120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979099 [patent_doc_number] => 06930103 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases' [patent_app_type] => utility [patent_app_number] => 10/607521 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7754 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930103.pdf [firstpage_image] =>[orig_patent_app_number] => 10607521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367584 [patent_doc_number] => 20040006060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Methods of treating hormone-related conditions using cyclothiocarbamate derivatives' [patent_app_type] => new [patent_app_number] => 10/601481 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16298 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 1091 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006060.pdf [firstpage_image] =>[orig_patent_app_number] => 10601481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702200 [patent_doc_number] => 20030225080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof' [patent_app_type] => new [patent_app_number] => 10/463814 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20434 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225080.pdf [firstpage_image] =>[orig_patent_app_number] => 10463814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224627 [patent_doc_number] => 20040072765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Cardiovascular and bone treatment using isoflavones' [patent_app_type] => new [patent_app_number] => 10/600004 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9119 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072765.pdf [firstpage_image] =>[orig_patent_app_number] => 10600004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711232 [patent_doc_number] => 07056945 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'Selective inhibition of neuronal nitric oxide synthase' [patent_app_type] => utility [patent_app_number] => 10/463213 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 13 [patent_no_of_words] => 4330 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056945.pdf [firstpage_image] =>[orig_patent_app_number] => 10463213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314633 [patent_doc_number] => 20040034065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Combination' [patent_app_type] => new [patent_app_number] => 10/362340 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5360 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034065.pdf [firstpage_image] =>[orig_patent_app_number] => 10362340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1224205 [patent_doc_number] => 06699889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Use of glucose uptake enhancer for reducing post-ischemic injury of the heart' [patent_app_type] => B2 [patent_app_number] => 10/459869 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4796 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699889.pdf [firstpage_image] =>[orig_patent_app_number] => 10459869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 766495 [patent_doc_number] => 07008936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/459972 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7266 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008936.pdf [firstpage_image] =>[orig_patent_app_number] => 10459972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 837010 [patent_doc_number] => 07393825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Microdose therapy' [patent_app_type] => utility [patent_app_number] => 10/460061 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 10852 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393825.pdf [firstpage_image] =>[orig_patent_app_number] => 10460061 [rel_patent_id] =>[rel_patent_doc_number] =>)